To this end, we pooled the Karaman et al. and Davis et al. datasets and filtered for FDA-approved inhibitors and their targets as listed in the PKIDB. The dataset preparation is described in detail in the Bioactivity profiling data section. We show the KiSSim method's performance in the form of ROC curves for each inhibitor's listed targets.